DaVita’s First Solar Thermal Dialysis Clinic Trial Shows Substantial Energy Reduction
September 29 2011 - 12:41PM
Business Wire
DaVita Inc. (NYSE: DVA), a leading provider of kidney care
services committed to improving the quality of life for those
diagnosed with chronic kidney disease (CKD), today announced the
company’s first-ever dialysis clinic using solar thermal technology
has shown a 75 percent reduction in natural gas consumption versus
comparable DaVita facilities in the region.
The solar thermal technology was installed as a trial at
DaVita’s Scottsburg, Ind., facility in 2010 and initial data has
been analyzed in 2011. In the dialysis process water must be heated
to a temperature equivalent to the human body before it is filtered
in the blood cleaning process. To lessen the amount of fossil fuels
consumed in the water heating process solar thermal panels were
installed on the roof of the facility, using the sun to naturally
increase the average temperature of water used for treatment.
“DaVita strives to identify innovative ways to reduce our energy
consumption,” said Kent Thiry, chairman and CEO of DaVita. “We’re
very encouraged by the initial results from this trial.”
DaVita will continue to analyze and evaluate the data for the
remainder of the year. If the pilot remains successful after this
time, DaVita hopes to expand the use of solar thermal technology at
more facilities across the country. In the meantime DaVita is
testing other energy reduction technologies, including a water
turbine in San Francisco, in an effort to continuously improve and
learn.
DaVita places a high value on reducing the company’s
environmental footprint and is credited with opening the nation’s
first LEED-certified dialysis facility as well as the first
dialyzer recycling pilot.
Visit DaVita’s newly launched sustainability page at
http://www.davita.com/about/sustainability to learn more about the
company’s efforts.
DaVita is a registered trademark of DaVita Inc. All other
trademarks are the property of their respective owners.
About DaVita
DaVita Inc., a Fortune 500® company, is a leading provider of
kidney care in the United States, delivering dialysis services to
patients with chronic kidney failure and end stage renal disease.
DaVita strives to improve patients’ quality of life by innovating
clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services.
As of June 30, 2011, DaVita operated or provided administrative
services at 1,669 dialysis facilities, serving approximately
131,000 patients. DaVita supports numerous programs dedicated to
creating positive, sustainable change in communities around the
world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern
Healthcare, Newsweek and WorldBlu. For more information, please
visit www.davita.com.
DaVita (NYSE:DVA)
Historical Stock Chart
From Jul 2024 to Aug 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Aug 2023 to Aug 2024